Back to all Programs

Register here

Related Materials

Past event

Global HIV Clinical Forum 2020

Update on COVID-19 in Persons with HIV Infection - Daniel Kuritzkes, MD

First-Line Therapy for HIV Infection - David Wohl, MD

Long Acting Injectable Antiretroviral Therapy - Martin Markowitz, MD

Implications of Drug Resistance for the HIV Pandemic - Robert Shafer,MD

Implications for Sanctuary Sites and Drug Interactions - Marta Boffito, MD, PhD

Implications for Women's Health - Sharon Walmsley, MD, FRCPC, CM

Clinical Case: Reduced Drug Therapy - Mary Montgomery, MD

How and When to Monitor Patients On Long-Acting Antivirals? - Monica Gandhi, MD, MPH

Strategies for Management of Drug-Drug Interactions With Long-Acting Therapies - David Back, PhD

Introducing New Therapies in Middle-Income Countries - Pedro Cahn, MD, PhD

Starting Long-Acting Drugs in the COVID-19 Era - Anton Pozniak, MD, FRCP

Therapeutic approaches for a sustainable remission and cure - Steven Deeks, MD

HIV Vaccines - Where Are We? - Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD

HIV Prevention: The Second Wave of Choices - Richard Elion, MD

Clinical Case: Potential Challenges of Drug Interactions of Long-Acting Agents - Catia Marzolini, PharmD, PhD

Clinical Update: Highly Treatment- Experienced Patients - Michael Kozal, MD